Kolexia
Geoffrois Lionnel Oncologie médicale
Geoffrois Lionnel
Oncologie médicale
Institut de cancérologie de Lorraine
Vandoeuvre-lès-Nancy, France
188 Activités
2 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Métastase tumorale Carcinome épidermoïde Tumeurs du rein Tumeurs de la tête et du cou Carcinome épidermoïde de la tête et du cou Tumeurs embryonnaires et germinales Mélanome

Collaborateurs

Voir plus
Gravis-Mescam Gwenaelle
Gravis-Mescam Gwenaelle
Centre Paoli-Calmettes, Marseille, France
Barthelemy Philippe
Barthelemy Philippe
Hôpital Civil, Strasbourg, France
Chevreau Christine
Chevreau Christine
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Rolland Frederic
Rolland Frederic
Institut de cancérologie de l'Ouest, Saint-Herblain, France

Industries

Voir plus
Ipsen
44 collaboration(s)
Dernière en 2023
MSD
20 collaboration(s)
Dernière en 2023
Novartis
11 collaboration(s)
Dernière en 2023
Pfizer
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
PERCIMEL: Personalized Circulating DNA Follow-up in Melanoma
Essai Clinique (Institut de cancérologie de Lorraine)   04 mars 2024
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
European journal of cancer (Oxford, England : 1990)   03 février 2024
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors: A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors
Essai Clinique (Unicancer)   01 février 2024
PAXIPEM: Multicenter Phase II Study of Axitinib +/- Pembrolizumab in First Line Treatment for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC)
Essai Clinique (Centre Léon-Bérard)   24 janvier 2024
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.
Journal for immunotherapy of cancer   09 novembre 2023
GIG-T: Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
Essai Clinique (Gustave-Roussy)   18 octobre 2023
EV-103: A Study of Enfortumab Vedotin (ASG-22CE) as Monotherapy or in Combination With Other Anticancer Therapies for the Treatment of Urothelial Cancer
Essai Clinique (Astellas)   17 octobre 2023
Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial.
European urology oncology   07 octobre 2023
Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma: A Phase 2 Study Evaluating Futibatinib (TAS 120) Plus Pembrolizumab in the Treatment of Advanced or Metastatic Urothelial Carcinoma
Essai Clinique (Taiho Oncology, Inc.)   05 octobre 2023
2182P Patient involvement to improve prospective follow-up: Quality of life data after cancer immunotherapy from the PRAISE study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023